Search - tctmd.com

Displaying 781 - 800 of 820

Sort: Relevancy | Date

News Industry News

Medtronic Resolute Integrity™ Drug-Eluting Stent Obtains FDA Approval for Treating Coronary Artery Disease

February 19, 2012

News Industry News

Vascular Solutions Launches Reprocessing Service for Closurefast® Vein Catheters

January 31, 2012

News Conference News Cell Therapy 2012

Expedited Cell Therapy After STEMI Shows Promise

January 29, 2012

News Industry News

Use of drug-eluting balloons with bare metal stents do not show superiority over drug-eluting stents

November 09, 2011

News Industry News

Low CV Event Rate Prompts Closure of Prasugrel Trial

November 09, 2011

News Industry News

Scripps Health and The Medicines Company Announce Late Breaking BRIDGE Trial Results Presented at TCT

November 08, 2011

News Conference News

SAPPHIRE and CABANA Add More Validation for Carotid Artery Stenting

November 07, 2011

News Industry News

Regado Biosciences, Inc. Presents Positive Efficacy and Safety Substudy Data from the Phase 2b RADAR Trial for the REG1 Anticoagulation System

November 06, 2011

News Daily News

Thrombolysis with Immediate Transfer for PCI Safe for Rural STEMI Patients

November 02, 2011

News Industry News

Corindus Vascular Robotics to Host Presentation on Robotic-Assisted PCI at TCT 2011

October 26, 2011

News Daily News

Guidelines for Radiation Shield Use Can Optimize Operator Protection

Yael L. Maxwell

October 20, 2011

News Daily News

Meta-analysis: Everolimus-Eluting Stents Reduce Thrombosis vs. Other DES

September 14, 2011

News Industry News

Abbott Receives U.S. FDA Approval for RX Herculink Elite® Renal Stent System for Treatment of Renal Artery Disease

August 10, 2011

News Daily News

Meta-analysis Finds Equivalence Between First-, Second-Generation DES

L.A. McKeown

August 02, 2011

News Daily News

Women Have Less Neointimal Hyperplasia Than Men With ZES

Leah Lawrence

July 29, 2011

News Daily News

Apixaban Increases Major Bleeding in High-Risk ACS Patients

Jason Kahn

July 25, 2011

News Industry News

St. Jude Medical Announces First Implant of Portico Transcatheter Heart Valve

June 07, 2011

News Daily News

Switching to Bivalirudin Effective After Early Heparin Therapy in STEMI Patients

May 31, 2011

News Daily News

Meta-analysis Demonstrates Mixed Evidence on CABG in ACS Patients Taking Clopidogrel

Caitlin E. Cox

May 27, 2011

News Industry News

Boston Scientific Announces FDA Approval and U.S. Launch of PROMUS® 2.25 mm Everolimus-Eluting Coronary Stent System

May 25, 2011

Advertisement

Medtronic Resolute Integrity™ Drug-Eluting Stent Obtains FDA Approval for Treating Coronary Artery Disease

Vascular Solutions Launches Reprocessing Service for Closurefast® Vein Catheters

Expedited Cell Therapy After STEMI Shows Promise

Use of drug-eluting balloons with bare metal stents do not show superiority over drug-eluting stents

Low CV Event Rate Prompts Closure of Prasugrel Trial

Scripps Health and The Medicines Company Announce Late Breaking BRIDGE Trial Results Presented at TCT

SAPPHIRE and CABANA Add More Validation for Carotid Artery Stenting

Regado Biosciences, Inc. Presents Positive Efficacy and Safety Substudy Data from the Phase 2b RADAR Trial for the REG1 Anticoagulation System

Thrombolysis with Immediate Transfer for PCI Safe for Rural STEMI Patients

Corindus Vascular Robotics to Host Presentation on Robotic-Assisted PCI at TCT 2011

Guidelines for Radiation Shield Use Can Optimize Operator Protection

Meta-analysis: Everolimus-Eluting Stents Reduce Thrombosis vs. Other DES

Abbott Receives U.S. FDA Approval for RX Herculink Elite® Renal Stent System for Treatment of Renal Artery Disease

Meta-analysis Finds Equivalence Between First-, Second-Generation DES

Women Have Less Neointimal Hyperplasia Than Men With ZES

Apixaban Increases Major Bleeding in High-Risk ACS Patients

St. Jude Medical Announces First Implant of Portico Transcatheter Heart Valve

Switching to Bivalirudin Effective After Early Heparin Therapy in STEMI Patients

Meta-analysis Demonstrates Mixed Evidence on CABG in ACS Patients Taking Clopidogrel

Boston Scientific Announces FDA Approval and U.S. Launch of PROMUS® 2.25 mm Everolimus-Eluting Coronary Stent System

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content